ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 315 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,646,000 | -14.8% | 61,404 | +14.1% | 0.00% | -25.0% |
| Q2 2023 | $1,932,240 | +122.6% | 53,809 | +60.4% | 0.00% | +100.0% |
| Q1 2023 | $868,000 | -31.7% | 33,552 | +6.4% | 0.00% | -33.3% |
| Q4 2022 | $1,271,000 | +86.1% | 31,546 | +52.4% | 0.00% | +50.0% |
| Q3 2022 | $683,000 | +16.4% | 20,700 | +23.8% | 0.00% | 0.0% |
| Q2 2022 | $587,000 | -24.6% | 16,727 | -1.5% | 0.00% | 0.0% |
| Q1 2022 | $779,000 | -27.8% | 16,988 | +4.8% | 0.00% | 0.0% |
| Q4 2021 | $1,079,000 | +99.1% | 16,206 | +76.8% | 0.00% | +100.0% |
| Q3 2021 | $542,000 | -27.4% | 9,164 | +1.5% | 0.00% | -50.0% |
| Q2 2021 | $747,000 | +12.0% | 9,031 | -9.9% | 0.00% | 0.0% |
| Q1 2021 | $667,000 | -27.7% | 10,021 | -16.5% | 0.00% | -50.0% |
| Q4 2020 | $922,000 | +176.0% | 12,008 | +54.8% | 0.00% | +100.0% |
| Q3 2020 | $334,000 | -0.3% | 7,756 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $335,000 | +62.6% | 7,756 | +8.4% | 0.00% | +100.0% |
| Q1 2020 | $206,000 | -69.2% | 7,158 | -38.5% | 0.00% | -75.0% |
| Q4 2019 | $668,000 | +152.1% | 11,641 | +9.7% | 0.00% | +300.0% |
| Q3 2019 | $265,000 | +6.0% | 10,616 | +12.7% | 0.00% | 0.0% |
| Q2 2019 | $250,000 | +18.5% | 9,416 | -22.0% | 0.00% | 0.0% |
| Q1 2019 | $211,000 | +58.6% | 12,071 | +9.5% | 0.00% | 0.0% |
| Q4 2018 | $133,000 | -47.4% | 11,024 | -18.6% | 0.00% | -50.0% |
| Q3 2018 | $253,000 | +1481.2% | 13,548 | +35.5% | 0.00% | – |
| Q1 2017 | $16,000 | +23.1% | 10,000 | -24.5% | 0.00% | – |
| Q4 2016 | $13,000 | -85.6% | 13,250 | +7.7% | 0.00% | -100.0% |
| Q3 2016 | $90,000 | +40.6% | 12,300 | +2.5% | 0.00% | 0.0% |
| Q2 2016 | $64,000 | – | 12,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,264 | $54,392,000 | 33.22% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $216,228,000 | 28.00% |
| L1 Capital Pty Ltd | 296,024 | $19,629,000 | 4.93% |
| Aquilo Capital Management, LLC | 407,926 | $27,050,000 | 4.89% |
| Evolutionary Tree Capital Management, LLC | 72,948 | $4,837,000 | 2.86% |
| ACUTA CAPITAL PARTNERS, LLC | 108,000 | $7,161,000 | 2.58% |
| First Light Asset Management, LLC | 536,836 | $35,598,000 | 2.36% |
| Parkman Healthcare Partners LLC | 70,089 | $4,648,000 | 1.08% |
| Hood River Capital Management LLC | 357,082 | $23,678,000 | 0.76% |
| Vanguard Capital Wealth Advisors | 11,099 | $703,565,000 | 0.60% |